Monsanto is facing thousands of Roundup lawsuits, all of which were filed on behalf of individuals diagnosed with non-Hodgkin’s lymphoma and related cancers following exposure to glyphosate, the active ingredient in the popular weed killer.
The nationwide law firm of Bernstein Liebhard LLP is offering free legal consultations to groundkeepers, landscapers, agricultural workers and others who were diagnosed with any of the following cancers following exposure to Roundup or one of Monsanto’s other glyphosate-containing herbicides:
To contact an experienced and qualified Monsanto Roundup lawyer today, please call (888) 994-5118 for you free, no-obligation case review.
Launched in 1974, Roundup is one of the most popular weed killers in the world.
Use of the glyphosate-containing herbicide has grown 3-fold since 1996, when Monsanto introduced Roundup Ready Crops. These genetically modified (GMO) versions of corn, soybeans, and other crops are resistant to the toxic effects of glyphosate, allowing farmers to use Roundup during the growing season.
By 2010, Roundup Ready Crops accounted for approximately 70% of the corn and cotton fields in the United States, as well as 90% of the country’s soybean fields.
In addition to Roundup, Monsanto – which was acquired by Bayer AG in 2017 – developed several other glyphosate-containing weed killers, including:
In March 2015, the World Health Organization’s international Agency for Research on Cancer (IARC) concluded an exhaustive investigation into the health affects potentially associated with glyphosate exposure. The review included:
The group concluded that glyphosate is “probably carcinogenic to humans” and specifically linked glyphosate exposure to non-Hodgkin lymphoma, including its various subtypes such as lymphocytic lymphoma / chronic lymphocytic leukemia, B-cell lymphoma and hairy cell leukemia.
Despite the findings, Monsanto continues to maintain that glyphosate is safe and has embarked on an aggressive campaign to discredit the IARC review. However, the agency continues to stand by the conclusions of its glyphosate investigation.
More than 4,000 plaintiffs have filed Roundup lawsuits in U.S. courts that accuse Monsanto of concealing the alleged link between Roundup and cancer.
In August 2018, a San Francisco jury convened to hear the nation’s first Roundup trial returned a $289 million verdict for the plaintiff, a former groundskeeper who developed terminal non-Hodgkin’s lymphoma after being exposed to Roundup 20-30 times per year over the course of his career.
During the trial, the plaintiff’s attorneys cited Monsanto internal documents showing that the company had reason to believe that glyphosate was dangerous as early as 1983, when a Monsanto-funded study discovered a statistically-significant increased risk of cancer in mice who were treated with the herbicide. However, the company dismissed the findings and refused an Environmental Protection Agency (EPA) request that the study be replicated.
Emails unsealed prior to trial also indicated that the Monsanto had ghostwritten two scientific papers that refuted the glyphosate-cancer connection. The EPA would rely on those studies when it found glyphosate to be safe in 2018.
Groundskeepers, farm workers and others who were diagnosed with Non-Hodgkin’s lymphoma or its various subtypes following exposure to Roundup or any of Monsanto’s glyphosate-based herbicides, or their surviving loved ones, may be entitled to compensation for:
To learn if you qualify to file a Roundup lawsuit, please contact our legal team by calling (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.